Top motivation: Weight loss is the leading reason for considering a GLP-1 or alternative (Canada: 58%
GLP-1 medications can run over $1,000 a month without coverage, a price tag that discourages many people from considering them
Real-world data with behavioural support Second Natures peer-reviewed research, published in JMIR Formative Research (2025), showed that semaglutide, combined with registered dietitian support and a structured behaviour change programme, produced an average 19.1% weight loss at 12 months, with 77.7% of participants achieving at least 10% weight loss
Monitoring Progress and Long-Term Success Regular monitoring ensures youre responding appropriately to your tirzepatide dosing for weight loss in units
Cytochrome P450 enzyme mediated herbal drug interactions (Part 2)
Older anti-obesity medications such as orlistat functioned mainly through local gastrointestinal mechanisms, inhibiting fat absorption and resulting in a weight loss of 23% (Bansal et al